
| GRANTS AND GOVERNMENT
PROGRAMS
A lucrative and underutilized source of start-up funding
for biotechnology, medical device technologies, and health care service
concepts is grant financing. The advantage of grant financing is that
it is non-dilutive to current investors meaning there is no expectation
of a return of capital to the granting source.
There are numerous examples of medical companies in Cleveland
that have been awarded >$1 million in grant funding to advance their technologies
and meet milestones that were critical to attracting next-stage growth
capital. In fact, some companies have even attracted $5-10 million or
more in total grant funding for their successful ventures. Entrepreneurs
should explore all grant funding possibilities that fit, but do not distract
from, their business and technology development plans.
-
SBIR/STTR Grants: The Small Business
Innovation Research (SBIR) and State Technology Transfer Research
(STTR) programs are federally mandated programs in which numerous
government agencies reserve a portion of their R&D funding to award
to small businesses. Under a competitive process, small business can
receive awards to engage in R&D projects with commercial potential.
The awards are:
-
Phase I (feasibility studies) awards of up to
$100,000
-
Phase II (research) awards of up to $750,000
-
Phase II continuation awards of up to $1 million
a year for 3 years
To qualify for SBIR funding, the company must be
incorporated and located in the U.S. , have fewer than 500 employees,
and be at least 51% owned by individuals. In addition, the Principal
Investigator'."'".'s primary employment during the project must be
with the company.
The STTR program facilitates collaboration between
businesses and research institutions on projects with commercial potential.
Initial awards range from $100,000 to >$1 million for projects.
The Small Business
Administration, Office of Technology and the
National Science Foundation web sites provide general information
on the programs and links to specific agency solicitations.
-
Other Federal Funds: In addition
to the well-known SBIR and STTR programs, entrepreneurs should explore
accessing government contracts and appropriations (non-competitive
allocations) to develop their concepts. Numerous agencies are interested
in advancing medical technologies and health care. For example, the
Defense agencies are very interested in the health care of military
personnel, while the Agriculture Department has a strong interest
in rural health. Companies can access these funds directly or in partnership
with a research organization. The range of these awards varies from
$50,000 to >$1 million in total size. To learn more, companies should
consult with government relations firms that are expert in supporting
small companies in accessing funds.
-
Health Care Foundations : Companies
should also explore funding possibilities from foundations that are
interested in the specific diseases or health system conditions that
the company is seeking to address. These foundations award significant
dollars both to companies directly as well as companies working with
research organizations for advancing medical technologies that advance
the understanding, treat the symptoms, or ultimately cure these diseases.
Well-know and large foundations exist for funding research and technologies
that can address most types of cancer, genetic conditions, and other
chronic diseases. In addition, foundations exist for funding improvements
to the health care system that address inefficiencies, safety, and
accessibility of health care. The awards can be very significant for
companies and their technologies, easily topping >$1 million over
time. To learn more, start your search at the
Foundation Center database.
Credit to this article goes to bioenterprise.com
|